Charlee Ann Cannon

Variable IL13Rα2 Expression Across Glioblastoma Models and Tumor Regions

Background: Interleukin-13 Receptor alpha 2 (IL13Rα2) is an attractive therapeutic target for glioblastoma because of its limited expression in normal brain tissue and overexpression in many tumors. However, the spatial heterogeneity of glioblastoma and limitations of conventiona...